GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY

Indian Pharmaceutical industry in the past four decades has achieved a very good growth rate in the market. This has been made possible as a result of globalization which not only has made the industry very competitive but also offered many choices of products to the consumers in the market. At the...

Full description

Bibliographic Details
Main Author: Arora, Gaurav
Format: Dissertation (University of Nottingham only)
Language:English
Published: 2009
Online Access:https://eprints.nottingham.ac.uk/23475/
_version_ 1848792576337903616
author Arora, Gaurav
author_facet Arora, Gaurav
author_sort Arora, Gaurav
building Nottingham Research Data Repository
collection Online Access
description Indian Pharmaceutical industry in the past four decades has achieved a very good growth rate in the market. This has been made possible as a result of globalization which not only has made the industry very competitive but also offered many choices of products to the consumers in the market. At the same time globalization has resulted in many challenges as well as opportunities for the pharmaceutical industry and now the pharmaceutical industry has to improve its efficiency to maximize their potential in the market. This dissertation is an attempt to analyze the challenges and opportunities which have resulted for the pharmaceutical companies operating in the market as a result of globalization and has also recommended certain measures through which it can improve its potential in the market. Pharmaceutical industry began its journey in 1970 with the passing of Patent Act 1970. With the passage of the Patents Act (1970), India excused itself from compliance with the standards of intellectual property (IP) protection in the United States of America and most European countries. Patents Act (1970) has made it completely legal in India to manufacture and sell pharmaceutical products that were under patent elsewhere in the world. Another major change in the scenario of Indian pharmaceutical industry came in 1995 when India joined World Trade Organization and the country agreed to implement the TRIPS. This was supplemented by the liberalization measures which have started by government as a part of its Industrial Policy 1991. The subsequent amendment carried out in 2005 in the Patent Act further increased the popularity of Indian pharmaceutical industry for the rest of the world. Post 1995, many multinational companies have entered into alliances apart from starting clinical trials in India. This research has attempted to uncover the challenges and opportunities posed before the Indian pharmaceutical industry and have also highlighted the methods through which the share of pharmaceutical industry in the market could be increased. Qualitative research methodology was used in this research and the results of data analysis show a positive picture of pharmaceutical industry in the market. The need today is to increase the expenditure on research and development so that new and innovative products and drugs could be introduced for the market. The pharmaceutical companies by reducing the cost of production and the cost of supply chain management can benefit from the new opportunities which have emerged in the Indian pharmaceutical industry.
first_indexed 2025-11-14T18:46:36Z
format Dissertation (University of Nottingham only)
id nottingham-23475
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T18:46:36Z
publishDate 2009
recordtype eprints
repository_type Digital Repository
spelling nottingham-234752018-01-22T12:33:41Z https://eprints.nottingham.ac.uk/23475/ GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY Arora, Gaurav Indian Pharmaceutical industry in the past four decades has achieved a very good growth rate in the market. This has been made possible as a result of globalization which not only has made the industry very competitive but also offered many choices of products to the consumers in the market. At the same time globalization has resulted in many challenges as well as opportunities for the pharmaceutical industry and now the pharmaceutical industry has to improve its efficiency to maximize their potential in the market. This dissertation is an attempt to analyze the challenges and opportunities which have resulted for the pharmaceutical companies operating in the market as a result of globalization and has also recommended certain measures through which it can improve its potential in the market. Pharmaceutical industry began its journey in 1970 with the passing of Patent Act 1970. With the passage of the Patents Act (1970), India excused itself from compliance with the standards of intellectual property (IP) protection in the United States of America and most European countries. Patents Act (1970) has made it completely legal in India to manufacture and sell pharmaceutical products that were under patent elsewhere in the world. Another major change in the scenario of Indian pharmaceutical industry came in 1995 when India joined World Trade Organization and the country agreed to implement the TRIPS. This was supplemented by the liberalization measures which have started by government as a part of its Industrial Policy 1991. The subsequent amendment carried out in 2005 in the Patent Act further increased the popularity of Indian pharmaceutical industry for the rest of the world. Post 1995, many multinational companies have entered into alliances apart from starting clinical trials in India. This research has attempted to uncover the challenges and opportunities posed before the Indian pharmaceutical industry and have also highlighted the methods through which the share of pharmaceutical industry in the market could be increased. Qualitative research methodology was used in this research and the results of data analysis show a positive picture of pharmaceutical industry in the market. The need today is to increase the expenditure on research and development so that new and innovative products and drugs could be introduced for the market. The pharmaceutical companies by reducing the cost of production and the cost of supply chain management can benefit from the new opportunities which have emerged in the Indian pharmaceutical industry. 2009-12-09 Dissertation (University of Nottingham only) NonPeerReviewed application/pdf en https://eprints.nottingham.ac.uk/23475/1/dissertation.pdf Arora, Gaurav (2009) GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY. [Dissertation (University of Nottingham only)] (Unpublished)
spellingShingle Arora, Gaurav
GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title_full GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title_fullStr GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title_full_unstemmed GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title_short GLOBALZATION AND RESULTING OPPORTUNITIES AND CHALLENGES FOR THE INDIAN PHARMACEUTICAL INDUSTRY
title_sort globalzation and resulting opportunities and challenges for the indian pharmaceutical industry
url https://eprints.nottingham.ac.uk/23475/